The dilemma over foreign-language labeling of over-the-counter drugs.
Maciejewski
C S
CS
Southern Illinois University School of Law, Carbondale 62901.
D000329:Advertising / Q000331:legislation & jurisprudence; D001241:Aspirin / Q000009:adverse effects; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D017007:Duty to Warn; D006630:Hispanic or Latino; D006801:Humans; D007223:Infant; D007802:Language; D008297:Male; D004366:Nonprescription Drugs; D012202:Reye Syndrome / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D004366:Nonprescription Drugs; D001241:Aspirin